nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A glimmer of hope for older people with acute myeloid leukaemia
|
Bermúdez, Arancha |
|
|
7 |
10 |
p. e700-e701 |
artikel |
2 |
Association of donor IFNL4 genotype and non-relapse mortality after unrelated donor myeloablative haematopoietic stem-cell transplantation for acute leukaemia: a retrospective cohort study
|
Gadalla, Shahinaz M |
|
|
7 |
10 |
p. e715-e723 |
artikel |
3 |
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study
|
Passamonti, Francesco |
|
|
7 |
10 |
p. e737-e745 |
artikel |
4 |
Communicating sickle cell disease point-of-care testing results
|
Jaja, Cheedy |
|
|
7 |
10 |
p. e708-e709 |
artikel |
5 |
Correction to Lancet Haematol 2020; 7: e370–80
|
|
|
|
7 |
10 |
p. e710 |
artikel |
6 |
COVID-19 and haematological malignancy: navigating a narrow strait
|
Rubinstein, Samuel M |
|
|
7 |
10 |
p. e701-e703 |
artikel |
7 |
10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, phase 2 trial
|
DiNardo, Courtney D |
|
|
7 |
10 |
p. e724-e736 |
artikel |
8 |
Effects of the COVID-19 pandemic on supply and use of blood for transfusion
|
Stanworth, Simon J |
|
|
7 |
10 |
p. e756-e764 |
artikel |
9 |
Enrolment of racial minorities across 15 years of multiple myeloma randomised trials; calling on researchers to become agents of change
|
Mohyuddin, Ghulam Rehman |
|
|
7 |
10 |
p. e704-e706 |
artikel |
10 |
Evaluating prophylactic heparin in ambulatory patients with solid tumours: a systematic review and individual participant data meta-analysis
|
Schünemann, Holger J |
|
|
7 |
10 |
p. e746-e755 |
artikel |
11 |
Filling a gap in UK health services: the role of charities
|
The Lancet Haematology, |
|
|
7 |
10 |
p. e697 |
artikel |
12 |
Frosted branch angiitis after allogeneic haematopoietic stem cell transplantation in adult T-cell leukaemia-lymphoma
|
Kamoi, Koju |
|
|
7 |
10 |
p. e772 |
artikel |
13 |
Heparins as cancer therapy: in theory, they should have worked
|
Posch, Florian |
|
|
7 |
10 |
p. e703-e704 |
artikel |
14 |
IFNL4 and donor selection for matched unrelated donor haematopoietic stem-cell transplantation
|
Westervelt, Peter |
|
|
7 |
10 |
p. e698-e699 |
artikel |
15 |
Routine haematological parameters in COVID-19 prognosis
|
Pereyra, David |
|
|
7 |
10 |
p. e709 |
artikel |
16 |
Selinexor for relapsed or refractory diffuse large B-cell lymphoma: examining the artifact
|
Smith, Stephen D |
|
|
7 |
10 |
p. e707 |
artikel |
17 |
Selinexor for relapsed or refractory diffuse large B-cell lymphoma: examining the artifact – Authors' reply
|
Kalakonda, Nagesh |
|
|
7 |
10 |
p. e707-e708 |
artikel |
18 |
Tackling adherence in sickle cell disease with mHealth
|
Hankins, Jane S |
|
|
7 |
10 |
p. e713-e714 |
artikel |
19 |
Tail events with cancer treatment
|
Hilal, Talal |
|
|
7 |
10 |
p. e712 |
artikel |
20 |
The peripheral T-cell lymphomas: an unusual path to cure
|
Ma, Helen |
|
|
7 |
10 |
p. e765-e771 |
artikel |
21 |
46th virtual annual meeting of the EBMT
|
del Pozo Martín, Yaiza |
|
|
7 |
10 |
p. e711 |
artikel |